Palanikumar Ravindran

1.2k total citations
18 papers, 908 citations indexed

About

Palanikumar Ravindran is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Palanikumar Ravindran has authored 18 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Palanikumar Ravindran's work include HIV Research and Treatment (4 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Palanikumar Ravindran is often cited by papers focused on HIV Research and Treatment (4 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Palanikumar Ravindran collaborates with scholars based in United States, Switzerland and Germany. Palanikumar Ravindran's co-authors include Hans Bitter, Sriram Sridhar, Donavan T. Cheng, Jay S. Fine, John Allard, Laura Badi, Michael E. Burczynski, Daniel J. Chin, Sujit K. Ghosh and Simon P. Fletcher and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Palanikumar Ravindran

17 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Palanikumar Ravindran United States 14 280 221 197 182 149 18 908
Tsukasa Aihara Japan 15 329 1.2× 137 0.6× 192 1.0× 156 0.9× 78 0.5× 89 1.0k
Teresa K. Surowy United States 13 366 1.3× 61 0.3× 141 0.7× 348 1.9× 82 0.6× 20 1.0k
Weiwei Chen China 14 221 0.8× 57 0.3× 558 2.8× 149 0.8× 102 0.7× 45 890
Shaogui Wan China 23 709 2.5× 147 0.7× 254 1.3× 267 1.5× 480 3.2× 62 1.5k
Yanling Feng China 19 324 1.2× 106 0.5× 124 0.6× 216 1.2× 170 1.1× 70 1.1k
Xi Xu China 18 427 1.5× 111 0.5× 96 0.5× 154 0.8× 314 2.1× 50 947
Dolores Subirá Spain 15 144 0.5× 160 0.7× 179 0.9× 178 1.0× 32 0.2× 40 860
Karin Fransén Sweden 18 754 2.7× 115 0.5× 339 1.7× 153 0.8× 267 1.8× 35 1.4k
Jianping Sun China 18 444 1.6× 80 0.4× 69 0.4× 79 0.4× 138 0.9× 53 901
Danting Shen China 8 423 1.5× 295 1.3× 163 0.8× 326 1.8× 209 1.4× 10 1.1k

Countries citing papers authored by Palanikumar Ravindran

Since Specialization
Citations

This map shows the geographic impact of Palanikumar Ravindran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Palanikumar Ravindran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Palanikumar Ravindran more than expected).

Fields of papers citing papers by Palanikumar Ravindran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Palanikumar Ravindran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Palanikumar Ravindran. The network helps show where Palanikumar Ravindran may publish in the future.

Co-authorship network of co-authors of Palanikumar Ravindran

This figure shows the co-authorship network connecting the top 25 collaborators of Palanikumar Ravindran. A scholar is included among the top collaborators of Palanikumar Ravindran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Palanikumar Ravindran. Palanikumar Ravindran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Friedman, Claire F., Paolo A. Ascierto, Diwakar Davar, et al.. (2020). 393 First-in-human phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: initial phase 1 results. SHILAP Revista de lepidopterología. A239.1–A239. 5 indexed citations
3.
Magee, Mindy, et al.. (2017). Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment. Open Forum Infectious Diseases. 4(suppl_1). S430–S430. 8 indexed citations
4.
5.
Fletcher, Simon P., Daniel J. Chin, Lore Gruenbaum, et al.. (2015). Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B. PLoS Pathogens. 11(9). e1005103–e1005103. 36 indexed citations
6.
7.
Chen, Gang, Sandip Panicker, Subramaniam Apparsundaram, et al.. (2013). Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. Molecular Immunology. 54(3-4). 355–367. 64 indexed citations
8.
Cheng, Donavan T., X. Cynthia, Jens Niewoehner, et al.. (2013). Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. Journal of Allergy and Clinical Immunology. 132(2). 455–462. 42 indexed citations
9.
Peng, Ruoqi, Sriram Sridhar, Gaurav Tyagi, et al.. (2013). Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease. PLoS ONE. 8(4). e59348–e59348. 164 indexed citations
10.
Wang, Jingming, et al.. (2013). Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells. European Journal of Immunology. 44(4). 1130–1136. 31 indexed citations
11.
Cockayne, Debra A., Donavan T. Cheng, Benjamin Waschki, et al.. (2012). Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity. PLoS ONE. 7(6). e38629–e38629. 75 indexed citations
12.
Fletcher, Simon P., Daniel J. Chin, Yongmei Ji, et al.. (2012). Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology. 56(3). 820–830. 78 indexed citations
13.
Allantaz, Florence, Donavan T. Cheng, Tobias Bergauer, et al.. (2012). Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression. PLoS ONE. 7(1). e29979–e29979. 169 indexed citations
14.
Fletcher, Simon P., Daniel J. Chin, Donavan T. Cheng, et al.. (2012). Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B. Hepatology. 57(1). 13–22. 39 indexed citations
15.
Sridhar, Sainetra, Ruoqi Peng, Jonathan E. Phillips, et al.. (2012). Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD. Mucosal Immunology. 6(3). 474–484. 44 indexed citations
16.
Babiarz, Joshua, Sriram Sridhar, Palanikumar Ravindran, et al.. (2011). Determination of the Human Cardiomyocyte mRNA and miRNA Differentiation Network by Fine-Scale Profiling. Stem Cells and Development. 21(11). 1956–1965. 80 indexed citations
17.
Ravindran, Palanikumar & Sujit K. Ghosh. (2011). Bayesian Analysis of Circular Data Using Wrapped Distributions. Journal of Statistical Theory and Practice. 5(4). 547–561. 24 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsukasa Aihara Breakdown of academic impact, for papers by Teresa K. Surowy Breakdown of academic impact, for papers by Weiwei Chen Breakdown of academic impact, for papers by Shaogui Wan Breakdown of academic impact, for papers by Yanling Feng Breakdown of academic impact, for papers by Xi Xu Breakdown of academic impact, for papers by Dolores Subirá Breakdown of academic impact, for papers by Karin Fransén Breakdown of academic impact, for papers by Jianping Sun Breakdown of academic impact, for papers by Danting Shen
Rankless by CCL
2026